TrialAnnals of oncology : official journal of the European Society for Medical Oncology2024

Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ENGOT-OV26/GOG-3012 trial.

B J Monk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.